In an informational guide published by the Alzheimer’s Association on the official Alzheimer’s Association website, organizers detail the logistical framework behind the world’s largest event series dedicated to raising funds and awareness for Alzheimer’s care, support, and research.
The core initiatives outlined by the organization encompass several distinct public participation channels. Beyond the primary Walk to End Alzheimer’s, supporters can engage through the Do What You Love to End ALZ program, which allows individuals to turn personal hobbies and community gatherings into independent fundraisers. Additional large-scale engagement opportunities include RivALZ, a flag football event series designed to inspire action through athletic competition, and the Ride to End ALZ cycling event.
Team Captains Update Page Settings Through Participant Center
For participants organizing groups through the digital platform, administrative tools allow team captains to modify core page settings. According to guidance documented on Alzwalk Zendesk, team captains can update specific page elements directly from the Participant Center interface.
The administrative process requires users to log into their Walk account, go to the My Page section from the Participant Center menu, and select the My Team's Page tab. From this designated area, team leaders retain the ability to modify the team name, update the custom page link, upload or change team photos, and rewrite the accompanying team story.
However, platform parameters separate team profile customization from financial target adjustments. The Zendesk documentation clarifies that changing a team fundraising goal cannot be completed from the My Team’s Page tab; instead, financial targets must be managed directly from the primary Dashboard interface.
For researchers, physicians, and clinical professionals specializing in dementia science, the organization also operates the International Society to Advance Alzheimer’s Research and Treatment (ISTAART), serving as a professional hub for those involved in studying the causes and treatments of neurodegenerative disorders.
